SEMA3B and breast carcinoma: All SEMA3s except SEMA3B (P = 0.35) were significantly differentially expressed in breast cancer tumours compared to adjacent normal (P < .00001), where only SAEMA3F has significantly increased expression (Fig. 1 and Additional file 4: Figure S6A).